EIGER BIOPHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 15, 2023, Eiger BioPharmaceuticals, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for or against each matter and the number of abstentions and broker non-votes with respect to each matter. A more complete description of each matter is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2023.

Proposal 1-Election of Directors

                                 Final Voting Results
Nominees                           For        Withheld    Broker Non-Votes
Jeffrey S. Glenn, M.D., Ph.D.   23,346,453   2,036,859       7,952,548
Evan Loh, M.D.                  14,074,196   11,309,116      7,952,548
Amit K. Sachdev, J.D.           23,025,306   2,358,006       7,952,548

The Company's stockholders elected each of the three nominees for director to serve until the 2026 annual meeting of stockholders and until his respective successor is elected.

Proposal 2-Advisory Vote on Executive Compensation

             Final Voting Results
   For        Against      Abstain   Broker Non-Votes
9,827,476    15,512,014    43,822       7,952,548

The Company's stockholders did not approve, on an advisory basis, the compensation awarded to the Company's named executive officers, as disclosed in the Proxy Statement.

Proposal 3-Ratification of Selection of Independent Registered Public Accounting
Firm

             Final Voting Results
   For             Against          Abstain
33,163,930         165,047           6,883

The Company's stockholders ratified the selection by the Audit Committee of the Board of Directors of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.

No other matters were submitted for stockholder action.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses